JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 450 participants.
Also called NCT05064540
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 450 participants
- Sponsor
- Registry
-
NCT05064540
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT05064540. Randomized; no masking; primary purpose treatment. Start 2021-09-20 (actual); primary completion 2032-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
- Acronym
- JAGUAR
- Condition
- AAA
- Condition
- AAA - Abdominal Aortic Aneurysm
- Intervention (Device)
- Alto Abdominal Stent Graft System
- Intervention (Device)
- FDA Approved EVAR AAA Graft Systems
- Lead sponsor
- Endologix
Record details
- Record id
cardio:ct-nct05064540- Content hash
836c42c2f72761e357a2b911394f4350e1ec3908f4edeae6651c84be83c4b023